Allona A, Díaz Cabrera J A, Manchado P
Chemotherapy. 1977;23 Suppl 1:267-74. doi: 10.1159/000222059.
Fosfomycin has been used on 40 patients with serious urinary infections of different clinical nature, and produced by repetitive infection (prostatisms, carcinomas, lithiasis, hydronephrosis, etc.) The following were isolated in the urocultures: E. coli (60%), Klebsiella (15%), P. aeruginosa (15.0%), Proteus sp. (15.0%), Staphylococcus (5%), S. faecalis (2.5%) and Paracolobactrum coliforme (2.5%). All the germs isolated before treatment were sensitive to fosfomycin. The results, as regards response to the bacteriuria, were 71.4% eradication of the infection, 17.2% reinfections and 11.4% failures. The results are considered very satisfactory in view of the etiopathogenic nature of the processes under treatment.
磷霉素已用于40例患有不同临床性质严重泌尿系统感染的患者,这些感染由反复感染(前列腺炎、癌、结石、肾积水等)引起。尿培养中分离出以下病菌:大肠杆菌(60%)、克雷伯菌(15%)、铜绿假单胞菌(15.0%)、变形杆菌属(15.0%)、葡萄球菌(5%)、粪肠球菌(2.5%)和大肠副杆菌(2.5%)。治疗前分离出的所有病菌对磷霉素敏感。关于对菌尿症的反应,结果为感染根除率71.4%、再感染率17.2%和失败率11.4%。鉴于所治疗疾病的病因性质,这些结果被认为非常令人满意。